Barni S, Lissoni P, Mandelli D, Archili C, Real G, Sormani A L, Caprotti R, Tancini G
Division of Radiation Oncology, San Gerardo Hospital, Monza, Italy.
Int J Biol Markers. 1991 Apr-Jun;6(2):103-6. doi: 10.1177/172460089100600204.
It has been suggested that both the menstrual cycle phase and postoperative changes in prolactin (PRL) secretion at the time of surgery may influence the prognosis of breast cancer. The present study was carried out to evaluate the relation between menstrual cycle period and surgery-induced PRL variations. We evaluated 32 premenopausal women with operable breast carcinoma; 17 were in perimenstrual phase (days 1-6 and 21-28) and 15 were in the mid-cycle (days 7-20) period at the time of surgery. To investigate serum levels of PRL, venous blood samples were collected before and 7 days after surgery. Postoperative hyperprolactinemia occurred in 17/32 patients and it was statistically more frequent in patients surgically treated during the perimenstrual phase than in the mid-cycle phase (12/17 vs 5/15; p less than 0.05), while no other parameter (including axillary node and estrogen receptor status) showed a significant influence on hyperprolactinemia rate. The results suggest that in premenopausal breast cancer patients surgery-induced hyperprolactinemia may be influenced by the menstrual cycle phase at the time of surgery.
有人提出,月经周期阶段以及手术时催乳素(PRL)分泌的术后变化可能会影响乳腺癌的预后。本研究旨在评估月经周期与手术引起的PRL变化之间的关系。我们评估了32例可手术治疗的绝经前乳腺癌女性患者;其中17例在手术时处于围经期(第1 - 6天和第21 - 28天),15例在手术时处于月经周期中期(第7 - 20天)。为了研究PRL的血清水平,在手术前和手术后7天采集静脉血样本。32例患者中有17例术后出现高催乳素血症,围经期接受手术治疗的患者术后高催乳素血症的发生率在统计学上高于月经周期中期接受手术治疗的患者(12/17 vs 5/15;p < 0.05),而其他参数(包括腋窝淋巴结和雌激素受体状态)对高催乳素血症发生率均无显著影响。结果表明,在绝经前乳腺癌患者中,手术引起的高催乳素血症可能受手术时月经周期阶段的影响。